Isracann Advises on Recent Activities and 2022 Outlook
09. Februar 2022 08:30 ET
|
Isracann Biosciences Inc.
VANCOUVER, British Columbia, Feb. 09, 2022 (GLOBE NEWSWIRE) -- Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company” or “Isracann”) an Israel-based company focused on...
Isracann Biosciences Announces Listing on the CSE and Investor Relations Agreements
16. Oktober 2019 22:08 ET
|
Isracann Biosciences Inc.
VANCOUVER, British Columbia, Oct. 16, 2019 (GLOBE NEWSWIRE) -- Isracann Biosciences Inc. (CSE: IPOT) formerly Atlas Blockchain Group Inc. (CSE: AKE) (XFRA: A49) (OTCPINK: ATLEF) (the “Company”) is...
Atlas Blockchain Announces Conditional Approval of Transaction with Isracann Biosciences Inc.
25. September 2019 21:11 ET
|
Atlas Blockchain Group Inc.
VANCOUVER, British Columbia, Sept. 25, 2019 (GLOBE NEWSWIRE) -- Atlas Blockchain Group Inc. (CSE: AKE) (XFRA: A49) (OTCPINK: ATLEF) (the “Company” or “Atlas”) wishes to advise that further to its...